Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

3.390
-0.085-2.45%
Volume:128.80K
Turnover:436.87K
Market Cap:1.45B
PE:-6.40
High:3.475
Open:3.475
Low:3.320
Close:3.475
52wk High:16.800
52wk Low:2.800
Shares:429.00M
HK Float Shares:418.00M
Volume Ratio:0.19
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.530
ROE:-29.87%
ROA:-13.80%
PB:1.57
PE(LYR):-6.40
PS:8.08

Loading ...

ImmuneOnco secures FDA IND clearance for Phase Ib/II study of dual-targeting antibody IMM0306 in systemic lupus erythematosus

Bulletin Express
·
Aug 21

ImmuneOnco Wins FDA IND Clearance for Imm0306 Lupus Phase Ib/II Trial

Reuters
·
Aug 21

ImmuneOnco Biopharmaceuticals (Shanghai) - Receives FDA Approval for Ind Application of Imm0306 for Phase Ib/Ii Sle Trial

THOMSON REUTERS
·
Aug 21

ImmuneOnco to Convene 26 Aug 2026 Board Meeting for 1H26 Results and Interim Dividend Deliberation

Bulletin Express
·
Aug 14

ImmuneOnco Biopharmaceuticals Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 14

Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge

Stock News
·
Aug 11

Hong Kong Stock Movers: IMMUNEONCO-B (01541) Surges Over 14% as Subsidiary Secures First External Commercial Capital to Accelerate Non-Oncology Pipeline

Stock News
·
Aug 11

IMMUNEONCO-B shares surge nearly 10% in afternoon trading after subsidiary raises 50 million yuan

Stock News
·
Aug 07

IMMUNEONCO-B's Unit Receives 50 Million Yuan Capital Injection

Stock News
·
Aug 07

ImmuneOnco Affiliate ImmuneCare Attracts RMB 50 Million in Capital Increase for 15.83% Stake

Reuters
·
Aug 07

ImmuneOnco injects RMB50.00 million into ImmuneCare; retains 68.34% stake after capital boost

Bulletin Express
·
Aug 07

ImmuneOnco trims outstanding H-shares by 0.58 million in July; treasury stock rises to 2.02 million

Bulletin Express
·
Aug 06

IMMUNEONCO-B Implements ESOP-Driven Capital Injection into Non-Oncology Subsidiary, Adjusts Shareholding Structure

Bulletin Express
·
Jul 31

ImmuneOnco Clarifies Subsidiary Capital Increase as Employee Incentive Scheme Via ESOP Platform

Reuters
·
Jul 31

ImmuneOnco Completes HKD 0.19 Million H-Share Buyback, Issued Share Count Trimmed to 418.46 Million

Bulletin Express
·
Jul 24

Immuneonco Files HKEX Next-day Disclosure Return Reporting Share Repurchase for Treasury Shares

Reuters
·
Jul 24

IMMUNEONCO-B buys back 49,000 H-shares, treasury stock rises to 1.96 million

Bulletin Express
·
Jul 23

IMMUNEONCO-B (01541) Allocates HK$165,900 for Buyback of 49,000 Shares on July 23

Stock News
·
Jul 23

Immuneonco Files HKEX Next-day Disclosure Return on Share Repurchase Cancellation

Reuters
·
Jul 23

ImmuneOnco completes HK$0.22 million share repurchase; treasury shares rise to 1.91 million

Bulletin Express
·
Jul 22